How much does a course of treatment with gosatuzumab (Todavi) cost?

Gosatuzumab (Trodelvy) is a targeted therapy used to treat triple-negative breast cancer (TNBC) and other types of cancer. Because gosatuzumab is an immunotherapy drug, its treatment cost is relatively high. The specific cost depends on many factors such as the patient's treatment plan, length of treatment, and purchasing channel.

Standard treatment with gosatuzumab is usually adjusted based on the patient's specific condition, with a common dose of approximately10 mg/kg once every two weeks. For a typical treatment cycle, patients often receive multiple injections, so the total cost of treatment increases with time.

In China, since the drug has been approved and entered the market, the price is higher because it is an imported drug and treatment takes a long time. Specifically, the domestic price is about more than 8,000 per box. This price covers the cost of the drug itself, hospital services needed for treatment, and possible testing. Charging standards may vary in different regions and hospitals, and patients need to confirm the latest cost information with the hospital pharmacy or relevant medical institution before purchasing.

In addition, gosatuzumab is not currently included in China’s medical insurance catalog, which means that patients may need to purchase it at their own expense during treatment. Although the price of the drug is also higher in some overseas markets (such as the United States, Europe, etc.), through import channels, some patients can choose to purchase drugs from these countries and may obtain more favorable prices.

In general, the cost of gosatuzumab treatment is relatively high. Patients need to understand the cost information in detail before receiving treatment and communicate with their doctors based on their personal circumstances to ensure the feasibility and economy of the treatment.

Reference materials:https://www.trodelvy.com/